LABP-73

N/A

Report date: 2023/04/02 18:56:01
NME

Base Information

Drug NameLABP-73
Drug Alias NameNX73LABP73NX-73
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNLR family member X1 agonists
TargetsNLR family member X1
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLandos Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesLandos Biopharma Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A